Literature DB >> 19397257

Amphiphilic random glycopolymer based on phenylboronic acid: synthesis, characterization, and potential as glucose-sensitive matrix.

Xingju Jin1, Xinge Zhang, Zhongming Wu, Dayong Teng, Xuejiao Zhang, Yanxia Wang, Zhen Wang, Chaoxing Li.   

Abstract

This study is devoted to developing amphiphilic, random glycopolymers based on phenylboronic acid, which self-assemble to form nanoparticles (NPs), as a glucose-sensitive agent. Maleimide-glucosamine was copolymerized with 3-acryl aminophenylboronic acid in methanol at 70 degrees C. Using the nanoprecipitation method, NPs with a narrow size distribution were successfully generated. Transmission electron microscopic analysis showed that the NPs were well dispersed as individual, spherically shaped particles. The swelling behavior of the NPs and the in vitro release profiles of insulin at different glucose concentrations revealed definite glucose sensitivity of the glycopolymers. Further, circular dichroism spectroscopy demonstrated that the overall tertiary structure of the released insulin was not altered compared with standard insulin. The analysis of relative cell proliferation suggested that the glycopolymer NPs had good biocompatibility. The glycopolymers that responded to changes in the glucose concentration of the surrounding environment are being aimed for use in self-regulated insulin delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19397257     DOI: 10.1021/bm8010006

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  11 in total

Review 1.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

Review 2.  Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.

Authors:  Jinqiang Wang; Zejun Wang; Jicheng Yu; Anna R Kahkoska; John B Buse; Zhen Gu
Journal:  Adv Mater       Date:  2019-08-18       Impact factor: 30.849

Review 3.  Glucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria.

Authors:  Jianhai Yang; Zhiqiang Cao
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

Review 4.  Development of glucose-responsive 'smart' insulin systems.

Authors:  Nischay K Rege; Nelson F B Phillips; Michael A Weiss
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-08       Impact factor: 3.243

5.  Random amphiphilic copolymeric sub-micro particles as a carrier shielding from enzymatic attack for peptides and proteins delivery.

Authors:  Qingyi Meng; Limin Tian; Jiaxiang Wang
Journal:  J Mater Sci Mater Med       Date:  2012-02-25       Impact factor: 3.896

6.  Molecular Features Influencing the Release of Peptides from Amphiphilic Polymeric Reverse Micelles.

Authors:  Mahalia A C Serrano; Bo Zhao; Huan He; S Thayumanavan; Richard W Vachet
Journal:  Langmuir       Date:  2018-04-02       Impact factor: 3.882

7.  Glucose-sensitive polyelectrolyte nanocapsules based on layer-by-layer technique for protein drug delivery.

Authors:  Honglei Guo; Qianqian Guo; Tianci Chu; Xinge Zhang; Zhongming Wu; Demin Yu
Journal:  J Mater Sci Mater Med       Date:  2013-09-26       Impact factor: 3.896

8.  Non inflammatory boronate based glucose-responsive insulin delivery systems.

Authors:  Indrani Dasgupta; Eric A Tanifum; Mayank Srivastava; Sharangdhar S Phatak; Claudio N Cavasotto; Mostafa Analoui; Ananth Annapragada
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

9.  Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment.

Authors:  Jicheng Yu; Yuqi Zhang; Hunter Bomba; Zhen Gu
Journal:  Bioeng Transl Med       Date:  2016-10-03

Review 10.  Boronic Acid as Glucose-Sensitive Agent Regulates Drug Delivery for Diabetes Treatment.

Authors:  Li Zhao; Qiongwei Huang; Yangyang Liu; Qing Wang; Liyan Wang; Shanshan Xiao; Fei Bi; Jianxun Ding
Journal:  Materials (Basel)       Date:  2017-02-13       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.